ArticleJournal of translational autoimmunity2023

Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase.

Clodoveo Ferri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.